CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...